Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
482
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
-12.2K
-
Total reported value, excl. options
-
$10.5B
-
Value change
-
+$23.1M
-
Put/Call ratio
-
0.7
-
Number of buys
-
197
-
Number of sells
-
-248
-
Price
-
$226.45
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2020
551 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2020.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 482 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 50.5M outstanding shares and own 91.43% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.35M shares), VANGUARD GROUP INC (4.92M shares), FMR LLC (1.78M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.27M shares), STATE STREET CORP (1.14M shares), WELLS FARGO & COMPANY/MN (1.01M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (946K shares), BROWN ADVISORY INC (860K shares), MARSHALL WACE, LLP (813K shares), and AMERIPRISE FINANCIAL INC (762K shares).
This table shows the top 482 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.